A Glimpse of Evaxion Biotech's Earnings Potential

Evaxion Biotech EVAX is preparing to release its quarterly earnings on Tuesday, 2025-04-01. Here’s a brief overview of what investors should keep in mind before the announcement.

Analysts expect Evaxion Biotech to report an earnings per share (EPS) of $-0.15.

Evaxion Biotech bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Performance in Previous Earnings

The company’s EPS beat by $2.70 in the last quarter, leading to a 3.0% drop in the share price on the following day.

Here’s a look at Evaxion Biotech’s past performance and the resulting price change:

Stock Performance

Shares of Evaxion Biotech were trading at $1.74 as of March 28. Over the last 52-week period, shares are down 91.13%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Evaxion Biotech visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.